NGeneBio Co., Ltd.

Korea (South)
  • Booth: 674
Booth Profile

NGeneBio was founded in 2015 as a spin-off venture from Korea Telecom, develops in vitro diagnostics (IVD)/companion diagnostics (CDx) products and bioinformatics SW with cutting-of-edge technologies including next generation sequencing (NGS). The company launched NGS-based breast/ovarian cancer panel (BRCAaccuTest) with clinical analysis SW (NGeneAnalySys) and received CE-IVD and KFDA approval in 2017. Currently launched NGS panels and SW for solid tumor and hematological malignancies.

 Additional Info

Included in the Export Interest Directory?
Business Needs:
Distributor/Agent/Representative, Other
Products to be exported:
BRCAaccuTestPLUS(BRCA1/2 testing NGS kit) 
 HEMEaccuTest(Hematologic malignancies NGS kit) 
 SOLIDaccuTest(Solid tumor NGS kit) 
 NGeneAnalySys(clinical NGS analysis SW platform)
 IDaccuTest (STR Genetic profiling kit)
Countries of Interest:
Colombia, Japan, Mexico, Sweden, Switzerland, Thailand, United Kingdom, Vietnam